secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001641172-25-026040
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences receives Nasdaq deficiency notice for failing minimum equity requirement
--------------------------------------------------------------------------------

- Nasdaq notified Enveric on Aug 26, 2025 that stockholders' equity of $2.18M as of June 30, 2025 is below $2.5M minimum.
- Company has until Oct 10, 2025 to submit a plan to regain compliance; Nasdaq may grant a 180-day extension if plan is accepted.
- If plan is rejected, Company may appeal to a Nasdaq Hearings Panel.
- Company intends to submit a compliance plan and consider available options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000164117225026040/0001641172-25-026040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000164117225026040/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer